200 related articles for article (PubMed ID: 12610739)
41. Drug monitoring of quinine in men with nonsevere falciparum malaria: study in the Amazon region of Brazil.
Vieira JL; Midio AF
Ther Drug Monit; 2001 Dec; 23(6):612-5. PubMed ID: 11802092
[TBL] [Abstract][Full Text] [Related]
42. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
[TBL] [Abstract][Full Text] [Related]
43. Effects of Plasmodium falciparum infection on the pharmacokinetics of quinine and its metabolites in pregnant and non-pregnant Sudanese women.
Mirghani RA; Elagib I; Elghazali G; Hellgren U; Gustafsson LL
Eur J Clin Pharmacol; 2010 Dec; 66(12):1229-34. PubMed ID: 20717655
[TBL] [Abstract][Full Text] [Related]
44. Quinine: the rediscovered anti-malarial agent.
Amabeoku GJ
Cent Afr J Med; 1991 Oct; 37(10):329-33. PubMed ID: 1813128
[TBL] [Abstract][Full Text] [Related]
45. Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis.
Maka DE; Chiabi A; Obadeyi B; Mah E; Nguefack S; Nana P; Mbacham W; Mbonda E
Malar J; 2016 Dec; 15(1):587. PubMed ID: 27923381
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.
Krishna S; White NJ
Clin Pharmacokinet; 1996 Apr; 30(4):263-99. PubMed ID: 8983859
[TBL] [Abstract][Full Text] [Related]
47. Effect of the grapefruit flavonoid naringin on pharmacokinetics of quinine in rats.
Zhang H; Wong CW; Coville PF; Wanwimolruk S
Drug Metabol Drug Interact; 2000; 17(1-4):351-63. PubMed ID: 11201303
[TBL] [Abstract][Full Text] [Related]
48. Ventricular fibrillation in a 5-year-old child on therapeutic dose of quinine dihydrochloride infusion for acute malaria.
Busari O; Busari O
J Natl Med Assoc; 2008 Sep; 100(9):1063-5. PubMed ID: 18807436
[TBL] [Abstract][Full Text] [Related]
49. A study of the factors affecting the metabolic clearance of quinine in malaria.
Pukrittayakamee S; Looareesuwan S; Keeratithakul D; Davis TM; Teja-Isavadharm P; Nagachinta B; Weber A; Smith AL; Kyle D; White NJ
Eur J Clin Pharmacol; 1997; 52(6):487-93. PubMed ID: 9342585
[TBL] [Abstract][Full Text] [Related]
50. Optimal regimens of parenteral quinine.
White NJ
Trans R Soc Trop Med Hyg; 1995; 89(4):462-4. PubMed ID: 7570904
[No Abstract] [Full Text] [Related]
51. [Treatment of cerebral malaria in African children by intravenous quinine: comparison of a loading dose regimen to a regimen without a loading dose].
Assimadi JK; Gbadoé AD; Agbodjan-Djossou O; Ayéwada K; Goeh-Akué E; Kusiaku K; Dogba A; Adjogblé K; Gayibor A
Arch Pediatr; 2002 Jun; 9(6):587-94. PubMed ID: 12108312
[TBL] [Abstract][Full Text] [Related]
52. Treatment of chloroquine-resistant falciparum malaria with a combination of quinine, quinidine and cinchonine (LA40221) in adults by oral and intravenous administration.
Bunnag D; Harinasuta T; Vanijanonta S; Looareesuwan S; Chittamas S; Punnavut W; Berth J; Druilhe P
Acta Leiden; 1987; 55():139-49. PubMed ID: 3321829
[No Abstract] [Full Text] [Related]
53. Effect of dose size on the pharmacokinetics of orally administered quinine.
Sowunmi A; Salako LA
Eur J Clin Pharmacol; 1996; 49(5):383-6. PubMed ID: 8866633
[TBL] [Abstract][Full Text] [Related]
54. Comparison of intramuscular and intravenous quinine for the treatment of severe and complicated malaria in children.
Schapira A; Solomon T; Julien M; Macome A; Parmar N; Ruas I; Simão F; Streat E; Betschart B
Trans R Soc Trop Med Hyg; 1993; 87(3):299-302. PubMed ID: 8236398
[TBL] [Abstract][Full Text] [Related]
55. Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga Province, South Africa.
Athan E; Dürrheim DN; Barnes K; Mngomezulu NM; Mabuza A; Govere J
S Afr Med J; 2001 Jul; 91(7):592-4. PubMed ID: 11544977
[TBL] [Abstract][Full Text] [Related]
56. Multi-drug resistant Plasmodium falciparum malaria in Assam, India: timing of recurrence and anti-malarial drug concentrations in whole blood.
Dua VK; Dev V; Phookan S; Gupta NC; Sharma VP; Subbarao SK
Am J Trop Med Hyg; 2003 Nov; 69(5):555-7. PubMed ID: 14695096
[TBL] [Abstract][Full Text] [Related]
57. Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.
Watkins WM; Winstanley PA; Mberu EK; Kokwaro G; Murphy SA; Newton CJ; Mwangi I; Forster D; Marsh K
Br J Clin Pharmacol; 1995 Mar; 39(3):283-7. PubMed ID: 7619670
[TBL] [Abstract][Full Text] [Related]
58. The reproducibility of quinine bioavailability.
Paintaud G; Alván G; Ericsson O
Br J Clin Pharmacol; 1993 Mar; 35(3):305-7. PubMed ID: 8471408
[TBL] [Abstract][Full Text] [Related]
59. Effect of paracetamol on parasite clearance time in Plasmodium falciparum malaria.
Brandts CH; Ndjavé M; Graninger W; Kremsner PG
Lancet; 1997 Sep; 350(9079):704-9. PubMed ID: 9291905
[TBL] [Abstract][Full Text] [Related]
60. Intravenous artesunate for severe malaria.
Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
